MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
- Study HIC#:1304011902
- Last Updated:12/22/2022
We hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. the Artemis system will be used to collect one extra research biopsy from each ROI. An average of 2 ROIs are identified for each case; therefore an average of 2 additional biopsies would be required for this research study. These research biopsies will not affect prostate biopsies collected as part of standard clinical care.
- Age18 years - 80 years
- GenderMale only
For more information about this study, including how to volunteer, contact:
Darryl T. Martin
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact email@example.com, or call +18779788343 for more information.
Trial Purpose and Description
The investigators hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. These profiles will in turn enable better predictions of the malignant progression of prostate cancers in the settings of current clinical practice.
- Only subjects that have scheduled Artemis prostate biopsy with defined regions of interest will be included in this study
- Any subjects that are unable to provide informed consent will be excluded